5 followers
Biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system.
Exelixis
11 followers
Sarepta Therapeutics
9 followers
Spark Therapeutics
7 followers
Neurocrine Biosciences
6 followers
Intercept Pharmaceuticals
1 follower
Thermo Fisher Scientific
167 followers
Biogen
115 followers
Illumina
68 followers
Agilent Technologies
64 followers
Alexion Pharmaceuticals
34 followers
BeiGene
21 followers
Explore companies